www.stirlingproducts.net
Stirling Products (ASX:STI) is a manufacturer and marketer of proprietary and/or patented pharmaceutical products and natural health products for its own interests as well as on a contractual basis for third parties. Strategically, Stirling Products is positioned to capitalise on the rapidly changing conditions within the global pharmaceutical and health markets.
The Stirling Products corporate headquarters are in Sydney, Australia and its North American pharmaceutical manufacturing operations are based on Cape Breton, Nova Scotia, Canada.
Stirling operates through three main business units each managed by proven industry specialist managers:
- Pharmaceutical & Healthcare
- Research & Development
- Animal Products
Stirling Products in pre-open pending board and funding announcements
Stirling Products (ASX: STI) has been granted a trading halt by the ASX pending several announcements, with the company's shares placed in pre-open.
Stirling is set to announce changes in the board, along with a progress update with funding and positioning for a planned UK AIM dual listing.
The company will also update the market on the appointment of a chief executive officer, and the HDA drug delivery license.


















